Journals LibraryNHS NIHR - National Institute for Health Research
HTA - 09/92/01
Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease
Project title: Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease
Call to action: 14/122 NICE 22nd Wave MTA
Research type: Evidence Synthesis
Chief investigator: Dr Hazel Squires
Lead Author: Dr Hazel Squires
Contractor: The University of Sheffield
Co-investigators: Ms Andrea Shippam.
Started: April 2010 | Status: Published December 2011
Study finds that naftidrofuryl oxalate and cilostazol both appear to be effective treatments for adults presenting with intermittent claudication due to peripheral arterial disease with few serious adverse events; however, only naftidrofuryl oxalate is estimated to have an incremental cost per QALY gained below £20,000
Links to project documentation
The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.